HuGE Literature Finder
Records
1
-
2
The Prognostic Influence of BRAF Mutation and other Molecular, Clinical and Laboratory Parameters in Stage IV Colorectal Cancer. Pathology oncology research : POR 2016 Mar . Karadima Maria L, Saetta Angelica A, Chatziandreou Ilenia, Lazaris Andreas C, Patsouris Efstratios, Tsavaris Nikola |
Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trial. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010 Sep 5 (9): 1382-90. Ready Neal, Jänne Pasi A, Bogart Jeffrey, Dipetrillo Thomas, Garst Jennifer, Graziano Stephen, Gu Lin, Wang Xiaofei, Green Mark R, Vokes Everett E, |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 29, 2023
- Content source: